FDA approves Ozempic to reduce risk of kidney disease progression, cardiovascular death
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients with type 2 diabetes and chronic kidney disease.
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Marketing for the popular nicotine pouch product, Zyn, has been approved by the U.S. Food and Drug Administration to help ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback